World's Best Scientists 2026 revealed!
Peter A. Noseworthy

Peter A. Noseworthy

D-Index & Metrics

Medicine

D-Index
80
Citations
29383
World Ranking
16958
National Ranking
8504

Peter A. Noseworthy publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Peter A. Noseworthy sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 588 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Peter A. Noseworthy D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Peter A. Noseworthy sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 80 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Peter A. Noseworthy is affiliated with the Mayo Clinic in the United States and has a substantial record of research primarily in Medicine, with a focus on Cardiology and Cardiovascular Medicine. Their work encompasses several subfields, including Surgery, Radiology, Nuclear Medicine and Imaging, Epidemiology, and Economics and Econometrics.

Their research attention centers around topics such as:

  • Atrial Fibrillation Management and Outcomes
  • Cardiac Arrhythmias and Treatments
  • Cardiac electrophysiology and arrhythmias
  • ECG Monitoring and Analysis
  • Cardiac pacing and defibrillation studies
  • Cardiovascular Function and Risk Factors
  • Cardiac Imaging and Diagnostics

Recent papers authored or coauthored by Peter A. Noseworthy include:

  • Artificial intelligence-enhanced electrocardiography in cardiovascular disease management, 2021, Nature Reviews Cardiology
  • 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation, 2023, Journal of the American College of Cardiology
  • Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: A Scientific Statement From the American Heart Association, 2020, Circulation
  • Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure, 2021, Circulation
  • Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19), 2020, Mayo Clinic Proceedings

Frequent coauthors include:

  • Paul A. Friedman
  • Zachi I. Attia
  • Francisco López-Jiménez
  • Konstantinos C. Siontis
  • Anthony H. Kashou

Peter A. Noseworthy has published extensively in several leading venues, which include:

  • Circulation
  • Journal of the American College of Cardiology
  • European Heart Journal
  • Mayo Clinic Proceedings
  • Heart Rhythm

The scientist's research production comprises over nine hundred publications primarily in Medicine, with the majority focusing on Cardiology and Cardiovascular Medicine. Their studies contribute notably to understanding atrial fibrillation and cardiac arrhythmias, emphasizing clinical management, diagnostic techniques, and therapeutic outcomes.

Best Publications

  • Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial

    Douglas L. Packer;Daniel B. Mark;Richard A. Robb;Kristi H. Monahan

  • An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction.

    Zachi I Attia;Peter A Noseworthy;Francisco Lopez-Jimenez;Samuel J Asirvatham

  • Screening for cardiac contractile dysfunction using an artificial intelligence–enabled electrocardiogram

    Zachi I. Attia;Suraj Kapa;Francisco Lopez-Jimenez;Paul M. McKie

  • Common variants at ten loci influence QT interval duration in the QTGEN Study.

    Christopher Newton-Cheh;Christopher Newton-Cheh;Mark Eijgelsheim;Kenneth M Rice;Paul I W de Bakker;Paul I W de Bakker

  • Artificial intelligence-enhanced electrocardiography in cardiovascular disease management

    Konstantinos C. Siontis;Peter A. Noseworthy;Zachi I. Attia;Paul A. Friedman

  • Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.

    Xiaoxi Yao;Nilay D. Shah;Lindsey R. Sangaralingham;Bernard J. Gersh

  • Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.

    Xiaoxi Yao;Neena S. Abraham;Lindsey R. Sangaralingham;M. Fernanda Bellolio

  • Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19).

    John R. Giudicessi;Peter A. Noseworthy;Paul A. Friedman;Michael J. Ackerman

  • Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States

    Konstantinos C. Siontis;Konstantinos C. Siontis;Xiaosong Zhang;Ashley Eckard;Nicole Bhave

  • Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation

    Xiaoxi Yao;Neena S. Abraham;G. Caleb Alexander;William Crown

  • QTc prolongation, torsades de pointes, and psychotropic medications.

    Scott R. Beach;Christopher M. Celano;Peter A. Noseworthy;James L. Januzzi

  • Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: A Scientific Statement From the American Heart Association.

    Mina K. Chung;Lee L. Eckhardt;Lin Y. Chen;Haitham M. Ahmed

  • Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA Trial.

    Douglas L. Packer;Jonathan P. Piccini;Kristi H. Monahan;Hussein R. Al-Khalidi

  • Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association.

    Lin Y. Chen;Mina K. Chung;Larry A. Allen;Michael Ezekowitz

  • Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization

    Dan E. Arking;Sara L. Pulit;Sara L. Pulit;Sara L. Pulit;Lia Crotti;Pim Van Der Harst

  • Guidance for Cardiac Electrophysiology During the COVID-19 Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association.

    Dhanunjaya R Lakkireddy;Mina K Chung;Rakesh Gopinathannair;Kristen K Patton

  • Age and Sex Estimation Using Artificial Intelligence From Standard 12-Lead ECGs.

    Zachi I. Attia;Paul A. Friedman;Peter A. Noseworthy;Francisco Lopez-Jimenez

  • Renal Outcomes in Anticoagulated Patients With Atrial Fibrillation.

    Xiaoxi Yao;Navdeep Tangri;Bernard J. Gersh;Lindsey R. Sangaralingham

  • Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation

    Peter Noseworthy;Xiaoxi Yao;Neena Susan Abraham;Neena Susan Abraham;Lindsey R. Sangaralingham

  • Development and Validation of a Deep-Learning Model to Screen for Hyperkalemia From the Electrocardiogram.

    Conner D. Galloway;Alexander V. Valys;Jacqueline B. Shreibati;Daniel L. Treiman

Frequent Co-Authors

Paul A. Friedman
Paul A. Friedman Mayo Clinic
Bernard J. Gersh
Bernard J. Gersh Mayo Clinic
Christopher Newton-Cheh
Christopher Newton-Cheh Harvard University
Rickey E. Carter
Rickey E. Carter Mayo Clinic
Markus Perola
Markus Perola Finnish Institute for Health and Welfare
David O. Hodge
David O. Hodge Mayo Clinic
Jonathan P. Piccini
Jonathan P. Piccini Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in expanding your healthcare career options beyond a traditional MD degree? The healthcare field offers a variety of online degrees designed for professionals seeking flexibility, advancement, or a specialized focus.

For those drawn to leadership and management within hospitals and healthcare organizations, pursuing a healthcare administration online degree is a strong choice. If you are already a registered nurse, consider advancing your skills with adn to fnp bridge programs, which provide a streamlined path towards becoming a Family Nurse Practitioner.

Individuals passionate about public health and wellness may opt for an online bs in nutrition, enabling careers in dietetics, health education, or research. For those aiming for executive roles in healthcare, consider enrolling in one of the top cahme-accredited mha programs to gain prestigious credentials in healthcare administration.

These diverse online degree options open doors to clinical, administrative, and leadership positions—catering to a variety of professional goals within the rapidly evolving healthcare sector.

Best Scientists Citing Peter A. Noseworthy

Trending Scientists

Recently Published Articles